Donor-specific transfusion via the portal venous route induces prolongation of H-2-compatible but not H-2-incompatible cardiac graft survival

Andre C, Heremans JF, Vaerman JP, Cambiaso CL (1975) A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med 142: 1509–1519 Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford, pp 293–296 Battisto JR, Millen J (1962) Immunologic unresponsiveness produced in adult pigs by parenteral introduction of minute quantities of hapten or protein antigen. Proc Soc Exp Biol Med 111: 111 Brent L, Horsburgh T, Wood PJ (1980) Induction of suppressor cells and allograft tolerance. Transplant Proc 12: 464 Cantor HM, Dumont AE (1967) Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215: 744–745 Caulfield MJ, Shaffer D (1987) Immunoregulation by antigen-antibody complexes. J Immunol 138: 3680–3683 Eid A, Morecki S, Slavin S (1988) Induction of transplantation tolerance by intraportal injection of allogeneic bone marrow cells. Transplant Int 1: 109–112 Fabre JW, Morris PJ (1972) The mechanism of specific immunosuppression of renal allograft rejection by donor strain blood. Transplantation 14: 634–640 Fulmer RI, Cramer AT, Liebelt RA, Liebelt AG (1963) Transplantation of cardiac tissue into the mouse ear. Am J Anat 113: 273–285 Hall M, Gurley K, Dorsch SE (1987) Specific unresponsiveness in rats with prolonged allograft survival is dependent upon the graft and suppressor T cell. Transplant Proc 19: 495–496 Hanson DG, Vaz NM, Maia LCS, Lynch JM (1979) Inhibition of specific immune responses by feeding protein antigens. III. Evidence against maintenance of tolerance to ovalbumin by orally induced antibodies. J Immunol 123: 2337–2343 Hauptman S, Tomasi TB (1974) Antibodies to human albumin in cirrhotic sera. J Clin Invest 54: 122–125 Hellstrom I, Hellstrom KE (1972) Cell-mediated immunity and blocking antibodies to renal allografts. Transplant Proc 4: 369–371 Kenick S, Lowry RP, Forbes RDC, Lisbona R (1987) Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: what is “hepatic tolerance”? Transplant Proc 19: 478–480 Lasek W, Jakóbisiak M, Płodziszewska M, Szczytnicki W, Górecki D (1988) The role of drug timing and histoincompatibility barrier in prolongation of cardiac graft survival in mice treated with donor-specific blood and cyclophosphamide. Immunol Lett 17: 357–360 Lasek W, Jakóbisiak M, Grochowska M, Górecki D, Gniadecki R, Kaliński P (1989) The influence of pretransplant and posttransplant immunosuppression on cardiac graft survival in the donor-specific transfusion model in mice: comparison of effects of cyclophosphamide, procarbazine, cyclosporine and cortisone. Transplantation 47: 913–915 Maki T, Okazaki H, Wood ML, Monaco AP (1982) Mouse skin allograft model for study of pregraft blood transfusion. Transplant Proc 14: 394–396 Marquet RL, Haysteek G (1981) Induction of suppressor cells by donor-specific blood transfusions and heart transplantation in rats. Transplantation 31: 272 Mattingly JA, Waksman BH (1978) Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat's Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol 121: 1878–1883 Mattingly JA, Waksman BH (1980) Immunologic suppression after oral administration of antigen. II. Antigen-specific helper and suppressor factors produced by spleen cells of rats fed sheep erythrocytes. J Immunol 125: 1044–1047 Mattingly JA, Kaplan JM, Janeway CA Jr (1980) Two distinct antigen-specific suppressor factors induced by the oral administration of antigen. J Exp Med 152: 545–554 McLoughlin GA, Wu AV, Saporoschetz I, Nimberg R, Mannick JA (1979) Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma. Ann Surg 190: 297–303 Nagarkatti PS, Joseph S, Singal DP (1983) Induction of antibodies by blood transfusions capable of inhibiting responses in MLC. Transplantation 36: 695–698 Opelz G, Sengar DPS, Mickey MR, Terasaki P (1973) Effect of blood transfusion on subsequent kidney transplants. Transplant Proc 5: 253–259 Pollock RE, Lotzova E (1987) Surgical-stress-related suppression of natural killer cell activity: a possible role in tumor metastasis. Nat Immun Cell Growth Regul 6: 269–278 Qian J, Hashimoto T, Fujiwara H, Hamaoka T (1985) Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for DTH responses to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 134: 3656–3661 Qian J, Kokudo S, Sato S, Hamaoka T, Fujiwara H (1987) Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and DTH responses as well as allograft rejection. Transplantation 43: 538–543 Rao VK, Burris DE, Sollinger HW, Burlingham WJ (1988) Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats. Transplantation 45: 1145–1149 Rood JJ van (1983) Pretransplant blood transfusion: sure! but how and why. Transplant Proc 15: 915–916 Singal DP, Ludwin D, Joseph S (1986) Induction of antiidiotypic antibodies by blood transfusions. Transplantation 42: 632–635 Siskind GW (1984) Immunologic tolerance: In: Paul WE (ed) Fundamental immunology. Raven Press, New York, pp 537–573 Slade MS, Simmons RL, Yunis E, Greenberg LJ (1975) Immunodepression after major surgery in normal patients. Surgery 78: 363–371 Terasaki PI (1984) The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 37: 119–125 Triger DR, Alp MH, Wright R (1972) Bacterial and dietary antibodies in liver disease. Lancet I: 60 Triger DR, Cynamon MH, Wright R (1973) Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization. Immunology 25: 941–950 Yoshimura N, Kahan BD (1986) The requirement for the renal transplant to induce unresponsiveness by the combination of extracted histocompatibility antigen and cyclosporine. Transplantation 42: 642–646